NLRP3 and Cognitive impairment: NLRP3 recognizes the microbe-associated molecular patterns expressed by gut microbiota, and changes in microbial composition are associated with increased levels of NLRP3 in the plasma of patients with cognitive impairment and brain amyloidosis [52].